Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,888,000 | 2,752,000 | 4,477,000 | 12,027,000 | 7,023,000 |
| Receivables | 7,745,000 | 7,889,000 | 7,977,000 | 5,557,000 | 5,476,000 |
| Inventories | 5,668,000 | 5,483,000 | 5,051,000 | 4,906,000 | 4,625,000 |
| Other current assets | 2,799,000 | 2,652,000 | 2,608,000 | 2,234,000 | 2,136,000 |
| TOTAL | $18,100,000 | $18,776,000 | $20,113,000 | $24,724,000 | $19,260,000 |
| Non-Current Assets | |||||
| PPE Net | 8,529,000 | 8,448,000 | 8,333,000 | 7,049,000 | 6,560,000 |
| Intangibles | 59,644,000 | 61,099,000 | 62,037,000 | 38,836,000 | 39,294,000 |
| Other Non-Current Assets | 4,306,000 | 4,424,000 | 4,640,000 | 2,991,000 | 2,584,000 |
| TOTAL | $72,479,000 | $73,971,000 | $75,010,000 | $48,876,000 | $48,438,000 |
| Total Assets | $90,579,000 | $92,747,000 | $95,123,000 | $73,600,000 | $67,698,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,586,000 | 2,667,000 | 2,867,000 | 2,301,000 | 2,098,000 |
| Accrued Expenses | 1,722,000 | 1,634,000 | 2,427,000 | 1,816,000 | 1,492,000 |
| Other current liabilities | 2,722,000 | 2,871,000 | 2,655,000 | 1,442,000 | 1,470,000 |
| TOTAL | $10,997,000 | $12,070,000 | $13,436,000 | $7,753,000 | $6,925,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 29,250,000 | 31,389,000 | 32,333,000 | 21,688,000 | 18,773,000 |
| Other Non-Current Liabilities | 4,647,000 | 4,772,000 | 4,661,000 | 3,983,000 | 3,513,000 |
| TOTAL | $37,228,000 | $39,659,000 | $40,832,000 | $27,137,000 | $23,919,000 |
| Total Liabilities | $48,225,000 | $51,729,000 | $54,268,000 | $34,890,000 | $30,844,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 391,789 | 391,462 | 391,192 | 394,048 | 393,419 |
| Common Shares | 440,000 | 440,000 | 439,000 | 439,000 | 438,000 |
| Retained earnings | 39,074,000 | 37,528,000 | 35,431,000 | 33,876,000 | 32,076,000 |
| Other shareholders' equity | -2,663,000 | -2,281,000 | -2,267,000 | -2,654,000 | -2,630,000 |
| TOTAL | $42,354,000 | $41,018,000 | $40,855,000 | $38,710,000 | $36,854,000 |
| Total Liabilities And Equity | $90,579,000 | $92,747,000 | $95,123,000 | $73,600,000 | $67,698,000 |